Form 8-K - Current report:
SEC Accession No. 0001829126-25-004929
Filing Date
2025-07-08
Accepted
2025-07-07 21:50:33
Documents
14
Period of Report
2025-07-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blackhawkacq_8k.htm   iXBRL 8-K 34670
2 EXHIBIT 99.1 blackhawkacq_ex99-1.htm EX-99.1 7370
  Complete submission text file 0001829126-25-004929.txt   262451

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bkhau-20250707.xsd EX-101.SCH 4063
4 XBRL DEFINITION FILE bkhau-20250707_def.xml EX-101.DEF 27156
5 XBRL LABEL FILE bkhau-20250707_lab.xml EX-101.LAB 37607
6 XBRL PRESENTATION FILE bkhau-20250707_pre.xml EX-101.PRE 25776
16 EXTRACTED XBRL INSTANCE DOCUMENT blackhawkacq_8k_htm.xml XML 7187
Mailing Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506
Business Address 4125 BLACKHAWK PLAZA CIRCLE SUITE 166 DANVILLE CA 94506 203-520-7122
Black Hawk Acquisition Corp (Filer) CIK: 0002000775 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 001-41984 | Film No.: 251109432
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)